Team Member

Areas of Focus:

• Healthcare

Mr. Greenacre is currently Chairman of the Board of Directors of BMP Sunstone Corporation (f/k/a Beijing Med-Pharm Corporation), a China-based Pharmaceutical company. Prior to this, Mr. Greenacre served at SmithKline Beecham from 1973 through 1992, including service as Chairman of SmithKline Europe. Mr. Greenacre has also served as Chief Executive Officer of two life sciences companies, Zynaxis Inc. from 1993 to 1997 and Delsys Pharmaceutical Corp. from 1997 to 2001. He is currently on the Board of Directors of Cephalon, Inc., Curis, Inc., Orchestra Therapeutics, Inc. (formerly Immune Response Corp.), and Accusphere, Inc.